Literature DB >> 24867971

Deletion of the uracil permease gene confers cross-resistance to 5-fluorouracil and azoles in Candida lusitaniae and highlights antagonistic interaction between fluorinated nucleotides and fluconazole.

Frédéric Gabriel1, Ayman Sabra2, Sofiane El-Kirat-Chatel2, Sophie Pujol3, Valérie Fitton-Ouhabi2, Daniel Brèthes4, Karine Dementhon2, Isabelle Accoceberry1, Thierry Noël5.   

Abstract

We characterized two additional membrane transporters (Fur4p and Dal4p) of the nucleobase cation symporter 1 (NCS1) family involved in the uptake transport of pyrimidines and related molecules in the opportunistic pathogenic yeast Candida lusitaniae. Simple and multiple null mutants were constructed by gene deletion and genetic crosses. The function of each transporter was characterized by supplementation experiments, and the kinetic parameters of the uptake transport of uracil were measured using radiolabeled substrate. Fur4p specifically transports uracil and 5-fluorouracil. Dal4p is very close to Fur4p and transports allantoin (glyoxyldiureide). Deletion of the FUR4 gene confers resistance to 5-fluorouracil as well as cross-resistance to triazoles and imidazole antifungals when they are used simultaneously with 5-fluorouracil. However, the nucleobase transporters are not involved in azole uptake. Only fluorinated pyrimidines, not pyrimidines themselves, are able to promote cross-resistance to azoles by both the salvage and the de novo pathway of pyrimidine synthesis. A reinterpretation of the data previously obtained led us to show that subinhibitory doses of 5-fluorocytosine, 5-fluorouracil, and 5-fluorouridine also were able to trigger resistance to fluconazole in susceptible wild-type strains of C. lusitaniae and of different Candida species. Our results suggest that intracellular fluorinated nucleotides play a key role in azole resistance, either by preventing azoles from targeting the lanosterol 14-alpha-demethylase or its catalytic site or by acting as a molecular switch for the triggering of efflux transport.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24867971      PMCID: PMC4135975          DOI: 10.1128/AAC.00009-14

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  34 in total

Review 1.  Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions.

Authors:  A Vermes; H J Guchelaar; J Dankert
Journal:  J Antimicrob Chemother       Date:  2000-08       Impact factor: 5.790

2.  Metabolite-binding RNA domains are present in the genes of eukaryotes.

Authors:  Narasimhan Sudarsan; Jeffrey E Barrick; Ronald R Breaker
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

3.  Alternative identification test relying upon sexual reproductive abilities of Candida lusitaniae strains isolated from hospitalized patients.

Authors:  F François; T Noël; R Pépin; A Brulfert; C Chastin; A Favel; J Villard
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

4.  Genetic and physiological aspects of resistance to 5-fluoropyrimidines in Saccharomyces cerevisiae.

Authors:  R Jund; F Lacroute
Journal:  J Bacteriol       Date:  1970-06       Impact factor: 3.490

Review 5.  Colony morphology switching of Candida lusitaniae and acquisition of multidrug resistance during treatment of a renal infection in a newborn: case report and review of the literature.

Authors:  Anne Favel; Annie Michel-Nguyen; Florence Peyron; Claude Martin; Laurent Thomachot; Annick Datry; Jean-Philippe Bouchara; Svetlana Challier; Thierry Noël; Christiane Chastin; Patrick Regli
Journal:  Diagn Microbiol Infect Dis       Date:  2003-09       Impact factor: 2.803

6.  Development of an integrative transformation system for the opportunistic pathogenic yeast Candida lusitaniae using URA3 as a selection marker.

Authors:  Fabienne François; Florence Chapeland-Leclerc; Jean Villard; Thierry Noël
Journal:  Yeast       Date:  2004-01-30       Impact factor: 3.239

7.  Clade-specific flucytosine resistance is due to a single nucleotide change in the FUR1 gene of Candida albicans.

Authors:  Andrew R Dodgson; Kirsty J Dodgson; Claude Pujol; Michael A Pfaller; David R Soll
Journal:  Antimicrob Agents Chemother       Date:  2004-06       Impact factor: 5.191

Review 8.  Candida lusitaniae infections in the era of fluconazole availability.

Authors:  Jimmy L Hawkins; Larry M Baddour
Journal:  Clin Infect Dis       Date:  2003-01-03       Impact factor: 9.079

9.  Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.

Authors:  Thierry Noël; Fabienne François; Patrick Paumard; Christiane Chastin; Daniel Brèthes; Jean Villard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

10.  Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.

Authors:  Zoë Steier; John-Paul Vermitsky; Geoffrey Toner; Scott E Gygax; Thomas Edlind; Santosh Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2013-08-26       Impact factor: 5.191

View more
  3 in total

1.  The Ca-loop in thymidylate kinase is critical for growth and contributes to pyrimidine drug sensitivity of Candida albicans.

Authors:  Chang-Yu Huang; Yee-Chun Chen; Betty A Wu-Hsieh; Jim-Min Fang; Zee-Fen Chang
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

Review 2.  Carrier-Mediated Drug Uptake in Fungal Pathogens.

Authors:  Mónica Galocha; Inês Vieira Costa; Miguel Cacho Teixeira
Journal:  Genes (Basel)       Date:  2020-11-09       Impact factor: 4.096

3.  Comparative transcriptome assembly and genome-guided profiling for Brettanomyces bruxellensis LAMAP2480 during p-coumaric acid stress.

Authors:  Liliana Godoy; Patricia Vera-Wolf; Claudio Martinez; Juan A Ugalde; María Angélica Ganga
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.